Get started
Author

Péter Bánhegyi

Observed names: Banhegyi P,, Banhegyi, P., Banhegyi, Péter, Bánhegyi, Péter, P Bánhegyi, P. Banhegyi, Peter Banhegyi, PÉTER BÁNHEGYI
OpenAlex ID: A5025613561
Signalling Inhibitors Against Mycobacterium tuberculosis – Early Days of a New Therapeutic Concept in Tuberculosis
2008 · B. Hegymegi-Barakonyi, R. Szekely, et al. · Current Medicinal Chemistry · 36
Drug Discovery in the Kinase Inhibitory Field Using the Nested Chemical Library™ Technology
2005 · György Kéri, Zsolt Székelyhidi, et al. · Assay and Drug Development Technologies · 33
Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain
2019 · Boglárka Kántás, Rita Börzsei, et al. · International Journal of Molecular Sciences · 32
PDF
Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma
2018 · Zsófia Czudor, Mária Balogh, et al. · Bioorganic & Medicinal Chemistry Letters · 30
Synthesis of selective SRPK-1 inhibitors: Novel tricyclic quinoxaline derivatives
2005 · Zsolt Székelyhidi, János Pató, et al. · Bioorganic & Medicinal Chemistry Letters · 30
Targeted drug combination therapy design based on driver genes
2019 · Lilian Zsákai, Anna Sipos, et al. · Oncotarget · 22
PDF
Tyrosine kinase inhibitors - small molecular weight compounds inhibiting EGFR.
2009 · Bálint Hegymegi-Barakonyi, Dániel Eros, et al. · PubMed · 22
Prediction Oriented QSAR Modelling of EGFR Inhibition
2006 · C. Szantai-Kis, I. Kovesdi, et al. · Current Medicinal Chemistry · 12
In Silico, In Vitro and In Vivo Pharmacodynamic Characterization of Novel Analgesic Drug Candidate Somatostatin SST4 Receptor Agonists
2021 · Boglárka Kántás, Éva Szőke, et al. · Frontiers in Pharmacology · 11
PDF
Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes
2015 · Laura Simon-Szabó, Márton Kokas, et al. · Bioorganic & Medicinal Chemistry Letters · 11
PDF
Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters
2018 · Csilla Temesszentandrási-Ambrus, Szilárd Tóth, et al. · PLoS ONE · 7
PDF
Synthesis and Characterization of Novel Quinazoline Type Inhibitors for Mutant and Wild-Type EGFR and RICK Kinases
2008 · NÓRA BREZA, JÁNOS PATÓ, et al. · Journal of Receptors and Signal Transduction · 7
Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B
2018 · Pál Gyulavári, Bálint Szokol, et al. · Bioorganic & Medicinal Chemistry Letters · 5
New Method for the Synthesis of 2-Acylamino-1-benzothiophene-3-carboxamide Derivatives from the Corresponding Esters
2008 · Péter Bánhegyi, Frigyes Wáczek, et al. · Synthetic Communications · 1
[Development and study of structure-activity relationship of drugs against Mycobacterium tuberculosis].
2013 · Ferenc Baska, Edina Rita Székely, et al. · PubMed
Host cell signalling inhibitors against helicobacter pylori
2009 · Z Varga, Z Greff, et al. · Zeitschrift für Gastroenterologie
ChemInform Abstract: New Method for the Synthesis of 2‐Acylamino‐1‐benzothiophene‐3‐carboxamide Derivatives from the Corresponding Esters.
2009 · Peter Banhegyi, Frigyes Waczek, et al. · ChemInform
[Novel method for the synthesis of carboxamides from low reactivity esters: synthesis of 2-acylamino-1-benzothiophene-3-carboxamides].
2008 · Péter Bánhegyi, Frigyes Wáczek, et al. · PubMed
Curr. Med. Chem.
2006 · Szantai-Kis, C., Kovesdi, I., et al. · MPG.PuRe (Max Planck Society)
[Synthesis of thiophene and alpha-terthiophene derivatives with antiproliferative activity].
2005 · Zsolt Székelyhidi, János Pató, et al. · PubMed
Works count: 23
Citation count: 260
H-index: 10
I10-index: 10
Year
Topic
Type